SCHEMBL23192018

SCHEMBL23192018

NNC(=O)C1CCCCCCCCCCCCC1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC8 Q9BY41 1/20 0.61
HDAC6 Q9UBN7 1/20 0.61
EPHX1 P07099 1/20 0.50
CES2 O00748 1/20 0.50
CES1 P23141 1/20 0.50
TSHR P16473 3/20 0.47
MAPK1 P28482 1/20 0.47
HSD11B1 P28845 2/20 0.45
MAPT P10636 1/20 0.45
HTT P42858 1/20 0.45
PTPN1 P18031 1/20 0.45
HPGD P15428 1/20 0.45
HDAC3 O15379 1/20 0.44
HDAC1 Q13547 1/20 0.44
HDAC2 Q92769 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.43
HSD17B10 Q99714 1/20 0.43
NAAA Q02083 1/20 0.42
ALDH1A1 P00352 1/20 0.41
MEN1 O00255 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5519104 1.00 HDAC8 (0.61) HDAC8HDAC6EPHX1CES2CES1
SCHEMBL5527291 1.00 HDAC8 (0.61) HDAC8HDAC6EPHX1CES2CES1
SCHEMBL5520084 1.00 HDAC8 (0.61) HDAC8HDAC6EPHX1CES2CES1
SCHEMBL5525101 1.00 HDAC8 (0.61) HDAC8HDAC6EPHX1CES2CES1
SCHEMBL5511001 1.00 HDAC8 (0.61) HDAC8HDAC6EPHX1CES2CES1
SCHEMBL14823816 1.00 HDAC8 (0.61) HDAC8HDAC6EPHX1CES2CES1
SCHEMBL293980 1.00 HDAC8 (0.61) HDAC8HDAC6EPHX1CES2CES1
SCHEMBL5515422 1.00 HDAC8 (0.61) HDAC8HDAC6EPHX1CES2CES1
SCHEMBL14823812 1.00 HDAC8 (0.61) HDAC8HDAC6EPHX1CES2CES1
SCHEMBL21441786 0.97 HDAC8 (0.58) HDAC8HDAC6EPHX1CES2CES1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220017567-A1 METHODS OF GENERATING NANOARRAYS AND MICROARRAYS NAUTILUS SUBSIDIARY, INC. 2022-01-20 US disclosed
US-11203612-B2 Methods of generating nanoarrays and microarrays NAUTILUS BIOTECHNOLOGY, INC. (US) 2021-12-21 US disclosed
US-20210101930-A1 METHODS OF GENERATING NANOARRAYS AND MICROARRAYS NAUTILUS BIOTECHNOLOGY, INC. 2021-04-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210101930-A1 METHODS OF GENERATING NANOARRAYS AND MICROARRAYS NAPA, SSBP1, NASP HDAC8 3234/4885HDAC6 1925/4885EPHX1 4457/4885
US-11203612-B2 Methods of generating nanoarrays and microarrays NAPA, SSBP1, NASP HDAC8 3234/4885HDAC6 1925/4885EPHX1 4457/4885
US-20220017567-A1 METHODS OF GENERATING NANOARRAYS AND MICROARRAYS NAPA, SSBP1, NASP HDAC8 3234/4885HDAC6 1925/4885EPHX1 4457/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.